Join us for a webinar that connects traditional medical insights with the innovative world of omnichannel strategies. This session is for professionals familiar with traditional medical insights, eager to see how omnichannel approaches and insights can inform medical engagement strategies
This article explores how Sumitomo Pharma America (SMPA) leveraged H1’s advanced data capabilities to integrate diverse insights, enhance field medical strategies, and foster cross-functional collaboration across therapeutic areas.
This article based on the Oct 3, 2024 Insights FAWG Forum explores the potential for artificial intelligence (AI) to transform Medical Affairs, focusing on medical insights.
From the Spreadsheet Age to the Age of Generative AI: Where is your organization on the continuum of Insights Management? (And why no one “age” fits the needs of all teams.)
This session will delve into maximizing Medical Affairs’ performance and strategic impact through effective metrics and innovative approaches. Learn from industry experts about the strategic goals of Medical Affairs and its unique impact generation in a cross-functional environment. Discover essential metrics for assessing performance and best practices for implementation. Explore cutting-edge data generation methods and technological advancements to enhance data quality and impact measurement.
Key topics to be addressed include:
What is the strategic goal of Medical Affairs and how does it generate impact?
What are the key metrics to measure Medical Affairs’ performance and impact?
How can innovative data approaches enhance measuring Medical Affairs’ impact?
The MAPS Puerto Rico Roundtable hosted by Real Chemistry in March 2024 discussed the integration of digital platforms, AI, and personalized content to enhance engagement with healthcare providers (HCPs). The panel emphasized the shift towards real-time, tailored information delivery and the importance of leveraging insights from both traditional and digital sources to support effective engagement strategies while ensuring compliance.
In this podcast, we explore now that we appreciate the need to demonstrate impact and technologies exist that allow us to measure impact…what’s holding us back?
Getting your research published is challenging enough, but how do you know if you're choosing a journal that will deliver the right audience, and once published, how can you find out if your article is performing as it should? Publishing research is important for many reasons - peer review, establishing a public record, proving efficacy and safety - but without an audience to read, engage and - hopefully - act on your research, it could be taken as an empty gesture. Not all publications are created equal - but they all have a potential audience. Prior to publication, how can we ensure best practice in journal selection and publication performance? Then post publication how can we use data to drive new insights to support this crucial activity in Medical Affairs; analysing and contextualising the information to accurately understand what they mean within the context of your therapeutic area?
MEDICAL AFFAIRS: The Roles, Value and Practice of Medical Affairs in the Biopharmaceutical and Medical Technology Industries (Taylor & Francis, 2024)
The Medical Affairs Professional Society (MAPS) Insights Focus Area Working Group (FAWG) formed a subcommittee to identify best practices and recommend guidelines for an effective insights management process. The following slides are an overview of key success factors identified.